A review on the role of carnitine in the management of tamoxifen side effects in treated women with breast cancer

被引：12
|
作者：
El-Ashmawy, Nahla E. [1 ]
Khalil, Rania M. [2 ]
机构：
[1] Tanta Univ, Dept Biochem, Fac Pharm, Tanta, Egypt
[2] Delta Univ, Dept Biochem, Fac Pharm, Gamasah, Egypt
来源：
TUMOR BIOLOGY | 2014年 / 35卷 / 04期
关键词：
Breast cancer; Cancer prognosis; L-carnitine; Resistance; Side effects; Tamoxifen; ACETYL-L-CARNITINE; RANDOMIZED DOUBLE-BLIND; PROPIONYL-L-CARNITINE; FATTY-ACID SYNTHASE; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; OXIDATIVE STRESS; DEPRESSED MOOD; HUMAN CORNEAL; FATIGUE;
D O I：
10.1007/s13277-013-1477-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
l-carnitine is an antioxidant and is found to be a protective agent against many diseases including cancer. This review illustrates the possible role of l-carnitine as an add-on therapy to breast cancer patients maintained on tamoxifen. The objectives of carnitine treatment are diverse: improving tamoxifen-related side effects, offering better cancer prognosis by reducing the risk of developing cancer recurrence or metastasis, and modulating the growth factors which may be, in part, a prospective illustration to overcome tamoxifen resistance. So, it could be recommended to supplement l-carnitine to breast cancer patients starting tamoxifen treatment.
引用
收藏
页码：2845 / 2855
页数：11
相关论文
共 50 条
  • [41] The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review
    Fleeman, N.
    Martin Saborido, C.
    Payne, K.
    Boland, A.
    Dickson, R.
    Dundar, Y.
    Fernandez Santander, A.
    Howell, S.
    Newman, W.
    Oyee, J.
    Walley, T.
    HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (33) : XIII - +
  • [42] Perceptions of breast cancer and experience of side-effects by breast cancer survivors prescribed tamoxifen and aromatase inhibitors
    Hughes, Lyndsay
    Moss-Morris, Rona
    Hunter, Myra
    Norton, Sam
    Moon, Zoe
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2021, 28 (SUPPL 1) : S143 - S143
  • [43] TAMOXIFEN IN THE MANAGEMENT OF METASTATIC CANCER OF THE BREAST
    CONE, LA
    ROMANOFF, NE
    HELM, NA
    WESTERN JOURNAL OF MEDICINE, 1979, 131 (03): : 258 - 262
  • [44] Perceptions of breast cancer and experience of side-effects by breast cancer survivors prescribed tamoxifen and aromatase inhibitors
    Hughes, Lyndsay
    Moss-Morris, Rona
    Hunter, Myra
    Norton, Sam
    Moon, Zoe
    PSYCHO-ONCOLOGY, 2020, 29 : 8 - 8
  • [45] Tamoxifen treatment and gynecologic side effects: A review
    Mourits, MJE
    De Vries, EGE
    Willemse, PHB
    Ten Hoor, KA
    Hollema, H
    Van der Zee, AGJ
    OBSTETRICS AND GYNECOLOGY, 2001, 97 (05): : 855 - 866
  • [46] Management of chemotherapy side effects in breast cancer patients
    Caruana, Danika
    Azzopardi, Lilian M.
    Serracino-Inglott, Anthony
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 : 7 - 7
  • [47] The control of breast cancer: The role of tamoxifen
    Forbes, JF
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S5 - S19
  • [48] Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review
    Hind, D.
    Wyld, L.
    Reed, M. W.
    BRITISH JOURNAL OF CANCER, 2007, 96 (07) : 1025 - 1029
  • [49] Re: Tamoxifen and contralateral breast cancer: the other side
    Li, CI
    Malone, KE
    Weiss, NS
    Daling, JR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (22) : 1753 - 1753
  • [50] Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review
    D Hind
    L Wyld
    M W Reed
    British Journal of Cancer, 2007, 96 : 1025 - 1029
12345